Pharmafile Logo

Webinar: What do HCPs really want from pharma digital in 2026?

Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention.

To explore what this means for digital teams, we are hosting a live webinar on 19 March 2026 with senior digital leaders from Novo Nordisk, LEO Pharma and MSD.

Together we will discuss what HCPs truly value from pharma digital and what organisations should prioritise to stay relevant.

- PMLiVE

Digital engagement is now firmly embedded in clinical practice. Healthcare professionals regularly interact with pharmaceutical companies through websites, portals, webinars and email communications. But while the industry has invested heavily in digital capabilities, many clinicians still report frustration with how these experiences are delivered.
To better understand this gap, we recently conducted research exploring how healthcare professionals experience pharma digital today and what they actually value from it. Our study surveyed 225 senior clinicians across the UK, USA and Germany, providing a clear view of how digital engagement is perceived in real-world clinical practice.
One finding stood out in particular. 65% of HCPs told us they have reduced or stopped engaging with a pharma company because of poor digital experiences. Clinicians described filtering out interactions that felt repetitive, overly promotional or difficult to access, while engaging more readily with digital content that was relevant to their clinical context and easy to navigate.
The research suggests that healthcare professionals are not disengaging from pharma digital. Instead, they are becoming more selective. Across our findings, three factors consistently determined whether digital engagement earned attention: relevance, utility and experience.
If content does not clearly relate to an HCP’s specialty or patient population, it is quickly ignored. If it does not help clinicians answer practical questions or support their work, it is unlikely to be revisited. And if the experience itself is difficult or time-consuming, engagement drops quickly.
To explore these themes further, we are hosting a live webinar on 19 March 2026 examining what healthcare professionals really expect from pharma digital in the years ahead.
The session will be hosted by our CEO, Rob Verheul, who will be joined by senior digital leaders from across the pharmaceutical industry:
  • Iria Gala, VP Digital & Customer Engagement at Novo Nordisk
  • Ryan Twiname, Head of Global Digital Marketing and Customer Engagement at LEO Pharma
  • Yazan Iwidat, Global Omnichannel Experience Standards Lead at MSD
Together, we will discuss what “digital value” really means from an HCP perspective and what pharma organisations should prioritise if they want their digital engagement to remain relevant in 2026 and beyond.
For teams responsible for digital engagement, omnichannel strategy or HCP experience, the conversation will offer practical insight into how organisations can close the growing gap between digital activity and digital value.
You can register for the webinar here:https://us06web.zoom.us/webinar/register/WN_lB5EhreWTxic6-3-gOrhjQ#/registrationThe full research report, The Value Gap: What HCPs want from digital pharma in 2026, is also available to download from our website.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

How to successfully manage change and enable digital transformation within pharma

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.

How user research will help you create better digital products, whatever stage you’re at

User research provides valuable insight that will help you create better digital products and services, whatever stage you’re at.

Advancing digital engagement in pharma and healthcare: 2024 focus areas

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

Building trust with HCPs: 6 takeaways from our industry webinar

Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.

Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital

Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...

What are design systems and how can they help you elevate your digital products?

Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...

The impact of mindset on digital product success: Download our new whitepaper

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...